iodixanol has been researched along with Pancreatic Neoplasms in 5 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frehtman, V | 1 |
| Wohlfarth, D | 1 |
| Müller, M | 1 |
| Krebs, O | 1 |
| Leuchs, B | 1 |
| Kawamoto, S | 1 |
| Fuld, MK | 1 |
| Laheru, D | 1 |
| Huang, P | 1 |
| Fishman, EK | 1 |
| Loizou, L | 1 |
| Albiin, N | 1 |
| Leidner, B | 1 |
| Axelsson, E | 1 |
| Fischer, MA | 1 |
| Grigoriadis, A | 1 |
| Del Chiaro, M | 1 |
| Segersvärd, R | 1 |
| Verbeke, C | 1 |
| Sundin, A | 1 |
| Kartalis, N | 1 |
| Cattaneo, GM | 2 |
| Passoni, P | 2 |
| Sangalli, G | 1 |
| Slim, N | 1 |
| Longobardi, B | 1 |
| Mancosu, P | 2 |
| Bettinardi, V | 2 |
| Di Muzio, N | 2 |
| Calandrino, R | 1 |
| Gusmini, S | 1 |
| Cappio, S | 1 |
| Gilardi, MC | 1 |
| Reni, M | 1 |
| Del Maschio, A | 1 |
| Fazio, F | 1 |
1 review available for iodixanol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Fe | 2018 |
1 trial available for iodixanol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.
Topics: Aged; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Humans; Iopamidol; Male; Multidetector C | 2016 |
3 other studies available for iodixanol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application.
Topics: Glioblastoma; H-1 parvovirus; Humans; Oncolytic Virotherapy; Oncolytic Viruses; Pancreatic Neoplasms | 2023 |
Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Four-Dimension | 2010 |
Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.
Topics: Carcinoma, Pancreatic Ductal; Contrast Media; Humans; Pancreas; Pancreatic Neoplasms; Radiographic I | 2008 |